BioAdaptives

BioAdaptives Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of BioAdaptives (BDPT) as of Oct 25, 2026 is 2,822.64. In the previous year, Days Inventory Outstanding (DIO) was 807.61 — a change of 249.50% (higher).

Days Inventory Outstanding

2,822.64

YoY

249.50%

Last updated:

Days Inventory Outstanding (DIO) of BioAdaptives is 2025 2,822.64 . Days Inventory Outstanding (DIO) of BioAdaptives was 2024 807.61 . It decreases by 249.50% higher compared to the previous year.

The BioAdaptives Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2016
5,113.93 USD
Jan 1, 2019
804.46 USD
Jan 1, 2020
492.81 USD
Jan 1, 2021
179.27 USD
Jan 1, 2022
322.40 USD
Jan 1, 2023
314.30 USD
Jan 1, 2024
807.61 USD
Jan 1, 2025
2,822.64 USD
The BioAdaptives Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
2,822.64+249.50%
807.61+156.96%
314.30-2.51%
322.40+79.84%
179.27-63.62%
492.81-38.74%
804.46-84.27%
5,113.93—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioAdaptives Stock analysis

What does BioAdaptives do? BioAdaptives, Inc. generates revenue through the sale of health and wellness products including dietary supplements, specialty food items, and devices that optimize bioelectromagnetic availability. The company markets PrimiCell and PrimiLive under a product agreement with Ferris Holding, Inc., targeting consumers seeking cognitive enhancement, fatigue reduction, and anti-aging solutions. PrimiTrim serves the weight control segment, while Equine Regen and Equine Regen Plus are in advanced testing for veterinary use. The firm also develops a dog product, expanding its wellness offerings across human and animal health markets. Ferris Holding, Inc. provides the intellectual property and products that BioAdaptives markets, including PrimiCell and PrimiLive, which are positioned for cognition, focus, and emotional wellness. The company's advanced-stage products Equine Regen and Equine Regen Plus cater to the veterinary segment, with PrimiTrim addressing weight management needs. BioAdaptives' product portfolio spans nutraceuticals, devices, and specialty foods designed to improve physical and emotional wellness across multiple consumer segments. BioAdaptives focuses on selling devices and nutraceuticals that target cognitive performance, fatigue reduction, and anti-aging, with PrimiCell and PrimiLive as key products under the Ferris agreement. The company's weight control solution PrimiTrim appeals to consumers seeking wellness through diet, while Equine Regen and Equine Regen Plus target animal health providers. The firm's development of a dog product further diversifies its offerings in the wellness market. BioAdaptives is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioAdaptives stock

Days Inventory Outstanding (DIO) of BioAdaptives is 2,822.64 in 2025.

Days Inventory Outstanding (DIO) of BioAdaptives changed from 807.61 to 2,822.64, representing a 249.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) BioAdaptives since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s BioAdaptives with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — BioAdaptives

All Key Metrics — BioAdaptives